TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Late detection is a big problem in India, with screening hesitancy a behavioural barrier. A national policy that normalizes ...

Certain foods and habits can impact your chances of getting cancer in your lifetime. Here, we share the latest research as ...

Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the ...

Death rates due to breast cancer in 2025 are set to decrease for women across most age groups in Europe, according to a new ...

“This could be due to a combination of increased awareness and improvements in cancer detection and treatment. But the stark ...

Breast cancer mortality rates have stopped declining for women over 74 and under 40, largely due to rising diagnoses of ...

John Mulaney detailed the risk assessment test that helped his wife Oliva Munn discover her breast cancer diagnosis in 2023.

Arvinas stock plummets 53% on mixed data from phase III metastatic breast cancer study on lead pipeline candidate, vepdegestrant.